Ricardo Corral

665 total citations
21 papers, 294 citations indexed

About

Ricardo Corral is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, Ricardo Corral has authored 21 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 8 papers in Experimental and Cognitive Psychology and 6 papers in Pharmacology. Recurrent topics in Ricardo Corral's work include Treatment of Major Depression (6 papers), Schizophrenia research and treatment (6 papers) and Mental Health Research Topics (6 papers). Ricardo Corral is often cited by papers focused on Treatment of Major Depression (6 papers), Schizophrenia research and treatment (6 papers) and Mental Health Research Topics (6 papers). Ricardo Corral collaborates with scholars based in Argentina, Spain and Canada. Ricardo Corral's co-authors include Claudio Mencacci, Jerónimo Sáiz Ruiz, Anthony S. Hale, Valentim Gentil, Sandra Díaz, Jesús Ibarluzea, Aitana Lertxundi, Marie‐Odile Krebs, Mathias Zink and Josep María Haro and has published in prestigious journals such as Science Translational Medicine, Schizophrenia Bulletin and Environmental Research.

In The Last Decade

Ricardo Corral

20 papers receiving 281 citations

Peers

Countries citing papers authored by Ricardo Corral

Since Specialization

Citations

This map shows the geographic impact of Ricardo Corral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Corral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Corral more than expected).

Fields of papers citing papers by Ricardo Corral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Corral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Corral. The network helps show where Ricardo Corral may publish in the future.

Co-authorship network of co-authors of Ricardo Corral

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Corral. A scholar is included among the top collaborators of Ricardo Corral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Corral. Ricardo Corral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial 2025 ·Science Translational Medicine ·Baltazar Gomez‐Mancilla, Kenneth M. Dürsteler, Marc Vogel, Marcus Herdener, Marta Torrens, (unknown), Antoni Gual, Ricardo Corral, (unknown), (unknown), (unknown), Nicole Pezous, (unknown), (unknown), (unknown), Jang‐Ho Cha, Ricardo Dolmetsch	2
2	Tercer Consenso Argentino sobre el manejo de los Trastornos Bipolares. Tercera parte: Manejo de los Trastornos Bipolares en el contexto de situaciones especiales 2023 ·PubMed ·Marcelo Cetkovich, (unknown), (unknown), (unknown), (unknown), (unknown), Fernando Torrente, (unknown), Julián Bustin, (unknown), Ricardo Corral, (unknown), Sergio Strejilevich, (unknown), (unknown), (unknown), Gustavo Vázquez, (unknown)	0
3	Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD) 2023 ·PubMed ·Ricardo Corral, (unknown), Marcelo Cetkovich, Rodrigo Córdoba, (unknown), Clarissa Severino Gama, (unknown), Carlos López‐Jaramillo, Ricardo Alberto Moreno, Bernardo Ng, (unknown), Luis Risco, Hernán Silva, Gustavo Vázquez	2
4	Trastorno depresivo mayor y depresión resistente al tratamiento: un análisis epidemiológico en Argentina del estudio de Depresión resistente al tratamiento en América Latina 2022 ·PubMed ·(unknown), Ricardo Corral, (unknown), (unknown), (unknown), (unknown), (unknown)	2
5	Suicidality and Quality of Life in Treatment-Resistant Depression Patients in Latin America: Secondary Interim Analysis of the TRAL Study 2022 ·Frontiers in Psychiatry ·Ricardo Corral, (unknown), Lina María Agudelo Baena, (unknown), (unknown), Lucas C. Quarantini, Marco Antônio Caldieraro, (unknown), (unknown)	12
6	Tercer Consenso Argentino sobre el manejo de los Trastornos Bipolares. Primera Parte: introducción, método de trabajo y generalidades 2022 ·PubMed ·Marcelo Cetkovich, (unknown), (unknown), (unknown), (unknown), (unknown), Fernando Torrente, (unknown), Julián Bustin, (unknown), Ricardo Corral, (unknown), Sergio Strejilevich, (unknown), (unknown), (unknown), Gustavo Vázquez, (unknown)	1
7	Depression and suicidality severity among TRD patients after 1-year under standard of care: Findings from the TRAL study, a multicenter, multinational, observational study in Latin America 2022 ·PubMed ·Marco Antônio Caldieraro, Teng Chei Tung, Lina María Agudelo Baena, (unknown), Ricardo Corral, (unknown), (unknown), (unknown), (unknown)	3
8	Consenso argentino sobre diagnóstico y tratamiento de la esquizofrenia resistente al tratamiento 2021 ·Ricardo Corral	2
9	Does exposure to greenness improve children's neuropsychological development and mental health? A Navigation Guide systematic review of observational evidence for associations 2021 ·Environmental Research ·(unknown), Ricardo Corral, Aitana Lertxundi, Sandra Díaz, Jesús Ibarluzea	39
10	<p>Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia</p> 2019 ·Neuropsychiatric Disease and Treatment ·Cristina Domènech, Adriana Pastore, A. Carlo Altamura, Corrado Bernasconi, Ricardo Corral, Hélio Elkis, Jonathan Evans, Ashok Malla, Francesco Margari, Marie‐Odile Krebs, (unknown), Mathias Zink, Josep María Haro	11
11	Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study 2019 ·Psychiatry Research ·(unknown), Bernardo dos Santos, Carlo Altamura, Corrado Bernasconi, Ricardo Corral, Jonathan Evans, Ashok Malla, Marie‐Odile Krebs, (unknown), Mathias Zink, Josep María Haro, Hélio Elkis	11
12	Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study 2018 ·Psychiatry Research ·Josep María Haro, Carlo Altamura, Ricardo Corral, Hélio Elkis, Jonathan Evans, Marie‐Odile Krebs, Mathias Zink, Ashok Malla, Ignacio Méndez, Corrado Bernasconi, Justine Lalonde, (unknown)	27
13	Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time 2018 ·Social Psychiatry and Psychiatric Epidemiology ·Cristina Domènech, Carlo Altamura, Corrado Bernasconi, Ricardo Corral, Hélio Elkis, Jonathan Evans, Ashok Malla, Marie‐Odile Krebs, (unknown), Mathias Zink, Josep María Haro	6
14	S118. CAN THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) DIFFERENTIATE REFRACTORY FROM NON-REFRACTORY SCHIZOPHRENIA? A FACTOR ANALYTIC INVESTIGATION BASED ON DATA FROM THE PATTERN COHORT STUDY 2018 ·Schizophrenia Bulletin ·(unknown), Bernardo dos Santos, Carlo Altamura, Corrado Bernasconi, Ricardo Corral, Jonathan Evans, Ashok Malla, Marie‐Odile Krebs, (unknown), Mathias Zink, Josep María Haro, Hélio Elkis	1
15	Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study 2016 ·Human Psychopharmacology Clinical and Experimental ·(unknown), (unknown), Ricardo Corral, (unknown), (unknown), Giovanni Martinotti, (unknown), (unknown)	33
16	Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study 2015 ·Schizophrenia Research ·Josep María Haro, Carlo Altamura, Ricardo Corral, Hélio Elkis, Jonathan Evans, Ashok Malla, Marie‐Odile Krebs, Mathias Zink, Corrado Bernasconi, Justine Lalonde, (unknown)	29
17	P.2.b.042 Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder 2014 ·European Neuropsychopharmacology ·Reiner Heun, Ricardo Corral, Antti Ahokas, Humberto Nicolini, João Marques Teixeira, (unknown), F. Picarel-Blanchot, Christian de Bodinat	1
18	1643 – Efficacy Of Agomelatine In More Anxious Elderly Depressed Patients. a Randomized, Double-blind Study vs Placebo 2013 ·European Psychiatry ·Reinhard Heun, Ricardo Corral, Antti Ahokas, Humberto Nicolini, João Marques Teixeira, (unknown)	5
19	Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study 2010 ·International Clinical Psychopharmacology ·Anthony S. Hale, Ricardo Corral, Claudio Mencacci, Jerónimo Sáiz Ruiz, (unknown), Valentim Gentil	102
20	P.2.c.026 Superior antidepressant efficacy of agomelatine vs fluoxetine in severe major depressive disorder patients: a randomised, double-blind study 2009 ·European Neuropsychopharmacology ·Anthony S. Hale, Ricardo Corral, (unknown), Jerónimo Sáiz Ruiz, (unknown), Valentim Gentil	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact